Functional Lipids and Appetite Regulation
Status
Conditions
Treatments
Details and patient eligibility
About
To evaluate the short-term effects of structured lipids on appetite regulation.
Full description
Background Obesity is a major health problem worldwide, and it is a risk factor for several chronic disorders. Even small changes in energy intake, leading to a positive balance may lead to weight gain over time. Thus, slight modifications in food intake, such as the inclusion of foods that effect energy balance, may prevent weight gain and even facilitate weight loss. Replacing dietary fat with low-calorie fat (LCF), such as modified triglycerides with medium and long chained PUFA.may be an efficient way to reduce body fat.
Bray et al. (2002) has shown a sustained weight loss of ~6 kg over a 9 month period where one-third of a fat-reduced diet (25% fat) was replaced by olestra. This weight loss can not solely be explained by the decreased caloric content of olestra. Thus, inhibition of appetite leading to lower food intake, may be a potential mechanism of the observed weight loss.
A reduced absorption of LCF leaves undigested fatty acids in the middle and lower intestine, which may generate increased feelings of satiety and decrease caloric intake due to regulating peptides and hormones such (CCK, GLP-1, etc.). In addition, intraduodenal fatty acids may also promote distension of the stomach and distension of the intestine, which are well-known gastrointestinal signals controlling mechanisms for food intake.
Taken together, in addition to the acute reduction in caloric intake, LCF may encourage a gastrointestinal hormone response promoting beneficial effects on appetite regulation and energy balance.
Aims To evaluate the short-term effects of LCF on
Primary:
- Appetite sensations after a meal (VAS)
- Postprandiel secretion of appetite regulating hormones
- Ad libitum caloric intake 4,5-h subsequent to a fixed meal
Secondary:
• Palatability of the test meal
Sex
Ages
Volunteers
Inclusion criteria
- healthy males
- Normal weigh, e.i. BMI between 18,5-25 kg/m2
- age 18-40 years
Exclusion criteria
- donation of blood 3 monhts prior or during the study
- gastrointestinal disorders, diabetes, hypertension, hyperlipidemia, chronic infectious disease
- smoking
- consumption of more than 21 alcoholic drinks/week
- elite athletes
- on mediation
- diet supplements
Trial design
Primary purpose
Allocation
Interventional model
Masking
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal